PCDH10 and endometrial endometrioid carcinoma: Moreover, PCDH10 could suppress epithelial‐mesenchymal transition (EMT) and stemness in CRC by negatively regulating the EGFR/AKT/β‐catenin signalling pathway22 and defer the development of endometrial endometrioid carcinoma through the PCDH10–Wnt/β‐catenin–MALAT1 regulatory axis.23